View
About the views

Guided View. New to dividends? Yields, ex-dividend dates, payout ratios, DRIP: we explain every term as you browse, in plain English. Same data, with the help built in.

Expert View. You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Theme
Dividendly Independent dividend research

← Back to declarations

BIESF Biotest AG — dividend yield, history & ex-dividend dates

Other OTC· Annual dividend· Common Stock · Healthcare / Biotechnology

$32.00 ▲ $0.00(0.00%) as of Oct 29, 2026 06:20 UTC
Sponsored Advanced charts & data →

Biotest Aktiengesellschaft, a German biopharmaceutical company established in Dreieich in 1946, specializes in the research, development, production, and global commercialization of advanced biological therapeutics. Its operations are organized into key segments: Therapy, Plasma & Services, and Other. The company’s primary focus areas encompass critical medical needs within hematology (blood disorders), clinical immunology, and intensive care medicine. Biotest offers a comprehensive range of products, including specific treatments for hemophilia like Haemoctin and Vihuma for the acute and prophylactic management of hemophilia A, and Haemonine for similar applications in hemophilia B. Its portfolio also features immunotherapies such as Cytotect CP biotest for cytomegalovirus infections, Fovepta for hepatitis B prophylaxis in neonates, and Hepatect for preventing hepatitis B reinfection. Varitect addresses varicella zoster virus infections, while Intratect and IgG Next Generation are utilized for primary immune and secondary antibody deficiency syndromes, autoimmune conditions, and certain neurological indications. Additionally, Zutectra is available for hepatitis B re-infection prophylaxis following liver transplantation. Further extending its product line, Biotest provides solutions like Albiomin and Biseko to restore and sustain circulating blood volume, Cofact for clotting factor deficiencies, and Fibrinogen for congenital fibrinogen deficiency. Innovative treatments include Trimodulin for community-acquired pneumonia and COVID-19, as well as Pentaglobin for bacterial infections. Known as Biotest Serum-Institut GmbH until its renaming in 1986, the company has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.

Dividend Snapshot

StatusReduced
Last Dividend$0.0455Paid Jul 24, 2026
Forward Annual$0.05From the $0.0455 dividend declared Jun 12, 2026
FrequencyAnnual
Last Ex-DateJul 23, 2026The most recent ex-dividend date that has already passed.
1-Yr Growth9.3%Annual totals, 2024–2025
10-Yr Growth-5.5%Annual totals, 2015–2025

Research Scores

Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.

Dividend Safety Score

6/100

Very weak indicators

Complete data

Dividend Growth Score

25/100

Weak growth record

Complete data

Dividend Value Score

Not Rated

required input missing: yield history

DividendRank

25/100

Lower middle of the scale

Partial data

How the Dividend Safety Score is built for BIESF
InputValuePointsWeight
Earnings payout ratioNet loss to common shareholders (FY2025): dividends not covered by earnings 0 20%
FCF payout ratioFree cash flow negative (FY2025) 0 25%
Net debt / EBITDAEBITDA negative with net debt (FY2025) 0 15%
Interest coverageInterest coverage -1.2x (FY2025) 0 10%
Dividend record2 years of uninterrupted regular payments; suspension May 6, 2023, within 10 years: capped at 20 20 20%
Earnings stabilityNet income positive in 2 of the last 5 fiscal years (FY2021–FY2025) 15 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

How the Dividend Growth Score is built for BIESF
InputValuePointsWeight
5-year dividend growth5-year dividend CAGR 1.7% (2020–2025) 42 25%
Consecutive annual increases1 consecutive annual increase (through 2025) 25 20%
Payout headroomNet loss to common shareholders (FY2025): no headroom 0 20%
Earnings per share growth (3 years)EPS -1.79 (FY2025) from -0.80 (FY2022): negative at the end of the 3 years 0 15%
Revenue growth (3 years)Revenue CAGR 7.9% (FY2022–FY2025) 100 10%
10-year dividend growth10-year dividend CAGR -5.5% (2015–2025) 0 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

Key Metrics

Current Yield

0.14%

At the Oct 29, 2026 price

The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.

Annualized Dividend

$0.0455

Declared Jun 12, 2026

The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.

Frequency

A Annual

How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.

RSI (14)

100

As of Oct 29, 2026

Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.

52-Week Range

$32.00 – $32.00

Closes through Jun 09, 2025

The lowest and highest price over the past year, showing where today's price sits in its recent range.

Payout Ratio (FY2025)

n/a

Fiscal year to Dec 31, 2025

The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.

Years Paying

38

How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.

Price / Book (FY2025)

2.33

At fiscal year-end, Dec 31, 2025

Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.

S.A.F.E. Dividend Read

S.A.F.E. is a set of four checks on a dividend's record and the company's data, the same test used across the screener and our ranked lists. Solid: a Dividend Safety Score of 70+ and a yield of 2%+. Accelerating: at least three consecutive completed calendar years of higher total regular dividends. Flawless: since 1990, no calendar year whose total regular dividend fell more than 20% below the year before, and no suspension. Enduring: at least 20 years between the first and latest dividend in our records. All four met earns the S.A.F.E. flag.
S Solid
Below the Solid check (Dividend Safety Score 70+ and yield 2%+): Dividend Safety Score 6/100, yield 0.14%.
A Accelerating
Dividend growth has stalled — 1 consecutive annual increase(s), under the 3 this check looks for.
F Flawless
The record shows a gap in the regular dividend of more than 1.5 times its usual interval (a payment was due around May 2023).
E Enduring
38 years of dividend payments on record.

Quote & Key Data

ExchangeOther OTCThe stock exchange where the shares trade, such as NYSE or Nasdaq.
VolumeN/AHow many shares changed hands in the trading session dated beside this figure, a rough read on trading activity. Daily bars are refreshed on a slower cycle than the quoted price, so this session can be older than the price above.
Open$32.00Jun 09, 2025 sessionThe price at the start of the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Day Range$32.00 – $32.00Jun 09, 2025 sessionThe lowest and highest price during the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Prev Close$32.00Close of Jun 06, 2025The closing price from the session before the one dated beside these figures.
Market Cap$1.60BAs of Oct 29, 2026The company's total market value (share price times shares outstanding) on the date shown.
Shares Out49.99MImplied by market cap, Oct 29, 2026Shares outstanding implied by the market cap and share price on the date shown.
EPS (FY2025)EUR -1.79Fiscal year to Dec 31, 2025; reported in EUREarnings per share over the trailing twelve months (TTM), labeled with the end date of the latest reported quarter and shown in the company's reporting currency. Dividends are paid out of these earnings.
P/E (FY2025)-15.2At fiscal year-end, Dec 31, 2025Price-to-earnings ratio: the share price on the date shown divided by trailing-twelve-month earnings per share. A rough gauge of how richly the stock is valued.
Last Ex-DateJul 23, 2026Paid Jul 24, 2026The most recent ex-dividend date that has already passed.
Next Ex-DateN/ANone declared yetThe ex-dividend date of the next payment the company has declared, or that is scheduled when no declaration is on file. Future dates our data provider only projects are not shown.

Dividend Growth

3-Yr Growth (CAGR)3.6%Annual totals, 2022–2025The dividend's average annual growth rate over the period, compounded.
5-Yr Growth (CAGR)1.7%Annual totals, 2020–2025The dividend's average annual growth rate over the period, compounded.
Consecutive Increases1 yrAnnual totals through 2025The number of consecutive years the dividend has increased.

Adjusted Price History

Dividend History

Dividend Payment History

Ex-dividend calendar →
Amount Type Declared Ex-Date Record Pay
$0.0455 A Regular Jun 12, 2026 Jul 23, 2026 Jul 23, 2026 Jul 24, 2026
$0.0458 A Regular N/A Jul 22, 2026 Jul 23, 2026 Jul 24, 2026
$0.0470 A Regular May 21, 2025 Jul 03, 2025 Jul 04, 2025 Jul 07, 2025
$0.0430 A Regular Mar 28, 2024 May 08, 2024 May 09, 2024 May 13, 2024
$0.0423 A Regular Mar 29, 2022 May 06, 2022 May 09, 2022 May 10, 2022
$0.0483 A Regular Mar 30, 2021 May 12, 2021 May 13, 2021 May 17, 2021
$0.0433 A Regular Apr 08, 2020 May 11, 2020 May 12, 2020 May 13, 2020
$0.0448 A Regular Mar 28, 2019 May 08, 2019 May 09, 2019 May 10, 2019
$0.0471 A Regular Apr 04, 2018 May 16, 2018 May 17, 2018 May 18, 2018
$0.0833 A Regular Jul 20, 2017 Aug 31, 2017 N/A Sep 04, 2017
$0.0452 A Regular Mar 24, 2016 May 13, 2016 N/A May 13, 2016
$0.7419 A Regular Mar 25, 2015 May 08, 2015 N/A May 08, 2015
$0.8734 A Regular Mar 26, 2014 May 08, 2014 N/A May 08, 2014
$0.7339 A Regular N/A May 09, 2013 N/A May 10, 2013
$0.6469 A Regular N/A May 11, 2012 N/A May 11, 2012
$0.6222 A Regular N/A May 13, 2011 N/A May 13, 2011
$0.5087 A Regular N/A May 07, 2010 N/A May 07, 2010
$0.4854 A Regular N/A May 08, 2009 N/A May 08, 2009
$0.5636 A Regular N/A May 28, 2008 N/A May 28, 2008
$0.4076 A Regular N/A May 04, 2007 N/A May 04, 2007
$0.2321 A Regular N/A May 12, 2006 N/A May 12, 2006
$0.1382 A Regular N/A May 23, 2005 N/A May 23, 2005
$0.2726 A Regular N/A Jul 09, 2004 N/A Jul 09, 2004
$0.3067 A Regular N/A Jul 12, 2002 N/A Jul 12, 2002
$0.2647 A Regular N/A Jul 13, 2001 N/A Jul 13, 2001
$0.2440 A Regular N/A Jul 17, 2000 N/A Jul 17, 2000
$0.2609 A Regular N/A Jul 16, 1999 N/A Jul 16, 1999
$0.5485 A Regular N/A Jul 10, 1998 N/A Jul 10, 1998
$0.5574 A Regular N/A Jul 21, 1997 N/A Jul 21, 1997
$5.3680 A Regular N/A Jul 22, 1996 N/A Jul 22, 1996
$5.7784 A Regular N/A Jul 24, 1995 N/A Jul 24, 1995
$4.4058 A Regular N/A Jul 25, 1994 N/A Jul 25, 1994
$3.4782 A Regular N/A Jul 26, 1993 N/A Jul 26, 1993
$5.3832 A Regular N/A Jul 27, 1992 N/A Jul 27, 1992
$4.4656 A Regular N/A Jul 15, 1991 N/A Jul 15, 1991
$4.7696 A Regular N/A Jun 25, 1990 N/A Jun 25, 1990
$4.1984 A Regular N/A Jul 24, 1989 N/A Jul 24, 1989
$1.0892 A Special N/A Jul 25, 1988 N/A Jul 25, 1988

Peer Comparison

Selected Biotechnology dividend payers we cover, strongest DividendRank first — for context, not a recommendation.

TickerNameYield5-Yr GrowthStreakRank
TRSBF 3SBio Inc. 1.85% N/A 0 yrs 72
GENSF Genus plc 1.55% -3.6% 2 yrs 68
REGN Regeneron Pharmaceuticals, Inc. 0.46% N/A N/A 63
TECH Bio-Techne Corporation 0.44% 0.0% 0 yrs 59

Related Guides & Lists

BIESF dividend — frequently asked questions

Does Biotest AG pay a dividend?

Yes. Biotest AG (BIESF) currently pays a dividend. The annualized dividend is about $0.05 per share, a yield of approximately 0.14%.

What is Biotest AG's dividend yield?

Biotest AG's dividend yield is approximately 0.14%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.

How often does Biotest AG pay dividends?

Biotest AG pays dividends annually — 1 time per year.

How long has Biotest AG paid dividends?

Biotest AG has 38 years of dividend payments on record.

Data updated Oct 29, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.